52.50
0.04%
0.02
시간 외 거래:
52.51
0.010
+0.02%
전일 마감가:
$52.48
열려 있는:
$53
하루 거래량:
261.93K
Relative Volume:
0.56
시가총액:
$2.90B
수익:
$1.24B
순이익/손실:
$23.68M
주가수익비율:
1,050.00
EPS:
0.05
순현금흐름:
$108.67M
1주 성능:
+2.30%
1개월 성능:
-0.89%
6개월 성능:
-13.18%
1년 성능:
+17.00%
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
LIVN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
52.50 | 2.90B | 1.24B | 23.68M | 108.67M | 0.42 |
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-10-04 | 개시 | Goldman | Buy |
2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
2024-03-20 | 재확인 | Needham | Buy |
2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
2023-09-06 | 개시 | HSBC Securities | Hold |
2023-07-19 | 개시 | Robert W. Baird | Neutral |
2023-04-14 | 개시 | Mizuho | Neutral |
2022-12-21 | 개시 | Barclays | Equal Weight |
2022-04-06 | 개시 | Wolfe Research | Outperform |
2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
2021-12-03 | 개시 | Goldman | Buy |
2021-08-20 | 재확인 | Needham | Buy |
2021-07-20 | 업그레이드 | Needham | Hold → Buy |
2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
2020-09-02 | 개시 | Robert W. Baird | Outperform |
2020-06-26 | 재확인 | Needham | Buy |
2019-10-30 | 재확인 | Needham | Buy |
2019-02-28 | 재확인 | Needham | Buy |
2018-11-28 | 개시 | UBS | Neutral |
2018-08-02 | 재확인 | Needham | Buy |
2018-06-08 | 개시 | Stifel | Buy |
2018-05-31 | 재확인 | Needham | Buy |
2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
LivaNova PLC's (NASDAQ:LIVN) Has Had A Decent Run On The Stock market: Are Fundamentals In The Driver's Seat? - Simply Wall St
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - MSN
Quantbot Technologies LP Buys New Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC's (NASDAQ:LIVN) Stock Has Shown A Decent Performance: Have Financials A Role To Play? - Yahoo Finance
Wall Street Analysts Predict a 37.2% Upside in LivaNova (LIVN): Here's What You Should Know - Yahoo Finance
Implantable Cardioverter Defibrillator Market Size, Trends, - openPR
Perfusion Systems Market Size, Trends, Growth, Opportunities - openPR
Needham retains Buy on Livanova shares, cites impressive track record - Investing.com
Needham & Company LLC Reiterates "Buy" Rating for LivaNova (NASDAQ:LIVN) - MarketBeat
Algert Global LLC Purchases 47,008 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Segall Bryant & Hamill LLC Invests $2.13 Million in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova's SWOT analysis: sleep apnea platform potential drives stock outlook - Investing.com
LivaNova PLC (NASDAQ:LIVN) Shares Sold by Primecap Management Co. CA - MarketBeat
Principal Financial Group Inc. Has $9.01 Million Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Cornercap Investment Counsel Inc. Sells 10,684 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Position Boosted by Victory Capital Management Inc. - MarketBeat
10,067 Shares in LivaNova PLC (NASDAQ:LIVN) Acquired by Entropy Technologies LP - MarketBeat
LivaNova (NASDAQ:LIVN) Cut to "Buy" at StockNews.com - MarketBeat
State of New Jersey Common Pension Fund D Purchases 11,782 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova to Present at the Stifel, Wolfe, and Piper Sandler Healthcare Conferences - sharewise
Medical Implants Market Is Booming Worldwide 2024-2031 | Biotronik, Inc., Livanova Plc, NuVasive - openPR
LivaNova's (LIVN) Buy Rating Reaffirmed at Needham & Company LLC - MarketBeat
LivaNova PLC (LIVN) SEC Filing Summary - Quartzy
Shareholders Will Be Pleased With The Quality of LivaNova's (NASDAQ:LIVN) Earnings - Yahoo Finance
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve - Simply Wall St
Vagus Nerve Stimulation (VNS) Market Market Size, Trends, - openPR
LivaNova announces OSPREY clinical study meets safety/efficacy endpoints - TipRanks
LivaNova Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints - sharewise
LivaNova reports positive results in sleep apnea trial By Investing.com - Investing.com South Africa
LivaNova reports positive results in sleep apnea trial - Investing.com India
LivaNova plc (LIVN) Announces OSPREY Clinical Study Meets Primary Safety and Efficacy Endpoints - StreetInsider.com
Blood Recovery Machine Market is expected to reach revenue of USD 4,277.4 Mn by 2033, at 5.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
LivaNova (NASDAQ:LIVN) Upgraded by StockNews.com to Strong-Buy Rating - MarketBeat
LivaNova PLC (NASDAQ:LIVN) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
LivaNova (LIVN) Upgraded to Strong Buy: What Does It Mean for the Stock? - Yahoo Finance
How Much Upside is Left in LivaNova (LIVN)? Wall Street Analysts Think 38.2% - Yahoo Finance
Chest Drainage Catheters Market Driven by Advancements in Medical Devices | LivaNova PLC, Mediplus, - EIN News
Oversold Conditions For LivaNova (LIVN) - Nasdaq
LivaNova (NASDAQ:LIVN) Trading Down 3.9%Should You Sell? - MarketBeat
LivaNova Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Nisa Investment Advisors LLC Lowers Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Is a LivaNova PLC (LIVN) Promising Medical Stock with Growth Potential? - Insider Monkey
Emerald Advisers LLC Purchases 14,302 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year - Simply Wall St
Earnings Beat: LivaNova PLC Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Where are the Opportunities in (LIVN) - Stock Traders Daily
abrdn plc Purchases 70,618 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova maintains VNS Therapy classification By Investing.com - Investing.com Australia
LivaNova maintains VNS Therapy classification - Investing.com India
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):